ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

The March, Sept. 26: Events Planned In D.C., Around The U.S.

September 4, 1998

In Brief: Schilsky Named ASCO Chief Medical Officer

November 1, 2012

Panel May Take On OMB In Battle to Restore NCI Construction Funds; Two Will Be Funded In FY ‘83

November 12, 1982

In Brief: Clinton Appoints Breast Cancer coalition’s Fran Visco to President’s Cancer Panel

May 21, 1993

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73.

October 31, 2003